# Cadrenal (CVKD) — News

CVKD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cvkd/news

## Recent headlines

- [CKD shareholders to sell shares](https://www.ainvest.com/news/ckd-shareholders-sell-shares-2610) — AInvest Wire, Oct 7, 2026
  Recent activity among shareholders of Cadrenal Therapeutics (CKD) has drawn attention as several insiders and investors appear to be reducing their holdings. While no specific insider transactions have been reported for Cadrenal Therapeutics in the provided data, the broader context of shareholder…
- [Cadrenal Therapeutics - Phase 3 trial to assess bleeding as major safety endpoint using ISTH criteria](https://www.ainvest.com/news/cadrenal-therapeutics-phase-3-trial-assess-bleeding-major-safety-endpoint-isth-criteria-2608) — AInvest Wire, Aug 31, 2026
- [Cadrenal Therapeutics - FDA agrees to placebo control with standard anticoagulation in CAD-1005 phase 3 trial](https://www.ainvest.com/news/cadrenal-therapeutics-fda-agrees-placebo-control-standard-anticoagulation-cad-1005-phase-3-trial-2608) — AInvest Wire, Aug 31, 2026
- [Cadrenal Therapeutics - Co and FDA align on phase 3 study protocol for CAD-1005](https://www.ainvest.com/news/cadrenal-therapeutics-fda-align-phase-3-study-protocol-cad-1005-2608) — AInvest Wire, Aug 31, 2026
- [Cadrenal Therapeutics announces positive outcome from FDA type D meeting for phase 3 registration study of cad-1005 in heparin-induced thrombocytopenia](https://www.ainvest.com/news/cadrenal-therapeutics-announces-positive-outcome-fda-type-meeting-phase-3-registration-study-cad-1005-heparin-induced-thrombocytopenia-2608) — AInvest Wire, Aug 31, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).